Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alfa Laval launches the first premium separator system for single-use pharmaceutical processing

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has launched a unique separator system, Alfa Laval CultureOne™, for single-use processing in the biopharmaceutical industry. All product-contact parts in the separator system can be replaced after each batch which eliminates the risk of cross-contamination thereby increasing process hygiene and safety.The Alfa Laval CultureOne™ separator system will be used in processes for harvesting fragile cell cultures which later can be used for injectable drugs for treating life-threatening illnesses such as

Cabonline to postpone reporting of Quarterly Interim Report

The Board of Directors of Cabonline has decided to postpone the publication of the company's Quarterly Interim Report for the period January-March 2020.The Cabonline Group is strongly affected by the actions implemented by the authorities in order to limit the spread and the effects of the Covid-19 in the Nordic countries. As a result of reduced demand for Carboline’s services, the company has implemented extensive temporary layoffs in all the Nordic countries. The Board's assessment is that the drastically reduced number of staff in several of the Group's companies causes that additional

Fiskars Group to reduce working hours of office personnel due to COVID-19

Fiskars CorporationPress releaseApril 14, 2020 at 10.00 EEST Fiskars Group to reduce working hours of office personnel due to COVID-19 Fiskars Group continues to take proactive steps to mitigate the negative impact of the COVID-19 on its operations globally. Working hours are planned to be reduced among office personnel, subject to local legislation. In total, approximately 1,500 employees globally are expected to be affected by these plans. Employee consultations will be initiated in selected countries. In Finland, Fiskars will begin employee consultations on temporary layoffs

Invitation to media and analyst briefing for Ericsson Q1 2020 report

· Report to be released at approximately 7:00 AM CEST on April 22, 2020 · One conference call for analysts, investors and journalists at 9:00 AM CESTEricsson's (NASDAQ: ERIC) financial report for the first quarter 2020 will be published at approximately 7:00 AM CEST on April 22, 2020. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's website: www.ericsson.com/en/investors/financial-reports/interim-reports   Conference

Mr Green set for touch-down in Spain.

The popular iGaming brand Mr Green  is set to roll out in Spain after receiving a license by the Directorate General for the Regulation of Gambling (DGOJ).In January 2019, William Hill Group finalised the acquisition of MRG and the online Casino brand Mr Green. Mr Green, also known as The Gentleman of Online Gaming, has a strong focus on providing a premium gaming experience in a safe and responsible environment.Today, William Hill has a strong brand presence within the Spanish Sports Betting market. The launch of Mr Green will support the Group’s multi-brand

Delivery of DLB Norce Endeavour to new owner

Solstad Offshore ASA (“the Company”) informed in March of this year that Saipem Portugal Commercio Maritimo Ltd has exercised the purchase option for the DLB Norce Endeavour, and the Company is pleased to announce that delivery of the barge now has taken place. Skudeneshavn, April 14[th], 2020 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at +47 40 04 29 18 Solstad Offshore ASAwww.solstad.com

2020 Bulkers Ltd. (2020) – Commercial update March, 2020

Commercial update: In March 2020, the Company achieved average time charter equivalent earnings of approximately USD 16,300 per day, gross, including profit sharing for the scrubbers. The Company’s two vessels trading on index-linked time charter earned approximately USD 5,600 per day, gross, including average daily scrubber benefits of approximately USD 1,100 per day. The Company’s four vessels trading on fixed time charter earned approximately USD 21,600 per day, gross. The Baltic 5TC Capesize Index averaged USD 3,224 during March 2020. For further queries, please contact:

Invitation – Presentation of Q1 2020 Interim Report

Boliden will announce its Interim Report for the first quarter 2020 on Tuesday 28 April at 12.30 (CET). A press and analyst conference will be held on the same day at 14.30, which can be followed via webcast and telephone. The report will be presented by Boliden’s President and CEO Mikael Staffas, and CFO Håkan Gabrielsson. To participate, please call 5 minutes before the opening of the conference: · From Sweden +46 8 5664 2651 · From UK +44 333 3000 804 · From US +1 631 9131 422PIN Code: 69409035#   The presentation will be live webcasted at www.boliden.com. For

Notice of annual shareholders’ meeting in Polygiene AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.The shareholders of Polygiene AB, Reg. No. 556692-4287, are hereby invited to attend the annual shareholders’ meeting to be held on Friday 15 May 2020, at 12.00 p.m., at Malmö Börshus, Skeppsbron 2, in Malmö.Information regarding the coronavirusAs a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of Polygiene AB (“Polygiene”) has decided to keep planned speeches at the annual

Aegirbio has completed its first sale

Aegirbio, together with Abreos Biosciences, has started testing for personal follow-up of treatment of MS patients with Tysabri. The first samples from Dr. Foley have been tested this week. There are currently approximately 16,000 patients treated with Tysabri in the United States. The treatment costs about $ 78,000 per patient per year. Aegirbio will now concentrate on the 40 to 50 major clinics responsible for the treatment of most of these 16,000 patients. MoNator Tysabri is a test to determine the amount of active drug in the treated patient's blood and thus, for each individual,

Alfa Laval wins SEK 170 million offshore orders

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won two orders to supply Framo pumping systems to two customers in China and Singapore. The orders have a combined value of approximately SEK 170 million. The orders were booked late March in the Pumping Systems unit of the Marine Division, with deliveries scheduled for 2020 and 2021.The orders comprise pumping systems for firewater and crude oil offloading, slop and ballast duties. “In these extraordinary times I am pleased to announce these large orders for our Framo pumping systems. Framo

Finnair to deepen its cooperation with Juneyao Air

Finnair and Shanghai-based Juneyao Air have signed a Letter of Intent to deepen their cooperation between China and Europe subject to required regulatory approvals.   The aim is to establish a joint venture on the Helsinki – Shanghai route enabling Finnair and Juneyao Air to offer their corporate and leisure customers a seamless travel experience through a wider choice of destination, schedule and fare options via their main hubs, Helsinki Airport (HEL) and Pudong International Airport (PVG).  “Despite these immensely challenging times for our industry, we at Finnair remain steadfast

Trelleborg’s Board of Directors proposes to postpone dividend decision

The Board of Directors of Trelleborg has decided to withdraw the previous dividend proposal and instead propose that the Annual General Meeting resolves that no dividend will be paid. When the market has stabilized, and visibility of earnings has normalized, it is the Board’s ambition to call to an extraordinary general meeting later this year, to decide on a dividend for the 2019 fiscal year. The background to this proposal is the increased economic uncertainty and the public measures taken to slow down the spread of COVID-19 globally and their effects on the Group. Trelleborg has a

Akastor ASA: Invitation to presentation of first quarter results 2020

Akastor ASA will publish its first quarter 2020 results on Tuesday April 28, 2020 at 7:00 a.m. CET. The presentation will be available through a conference call and audiocast only, at 8:00 a.m. CET. The presentation will be audiocasted live, and available through a dial-in conference call. There will be a Q&A session following the presentation. The replay will be made available on the company website. Please join the event 5-10 minutes prior to the start time. You will be asked to provide the confirmation code and title of your conference. UK/International +44 (0)330 336 9105

Elkem completes Polysil acquisition

Oslo, 14 April 2020: Elkem ASA has now closed the previously announced acquisition of Polysil, a leading Chinese silicone elastomer and resins material manufacturer. Polysil has strong positions in baby care and food grade silicones, as well as silicone products for the electronics and medical markets. Polysil and Elkem's complementary product and market positions provide a solid platform for further specialisation and growth in China and globally. “We continue to develop Elkem’s competitive positions, at the same time as we work to safeguard our business in light of the coronavirus

Alma Media has been notified by shareholders representing a majority of the company’s shares that they support the proposals to the AGM to be held on 29 April 2020

Alma Media Corporation             Stock exchange release 14 April 2020 at 9.00 a.m. ALMA MEDIA HAS BEEN NOTIFIED BY SHAREHOLDERS REPRESENTING A MAJORITY OF THE COMPANY’S SHARES THAT THEY SUPPORT THE PROPOSALS OF THE SHAREHOLDERS’ NOMINATION COMMITTEE AND THE BOARD OF DIRECTORS TO THE AGM TO BE HELD ON 29 APRIL 2020 Alma Media Corporation’s Annual General Meeting will be held at 12:00 noon on Wednesday, 29 April 2020, at Alma Media’s head office at Alvar Aallon katu 3 C, 00100 Helsinki, Finland. Due to the coronavirus outbreak, the Annual General Meeting can only be held if the

Tagrisso adjuvant trial overwhelmingly positive

This announcement contains inside information   10 April 2020 18:00 BST Tagrisso Phase III ADAURA trial will be unblinded early after overwhelming efficacy in the adjuvant treatment of patients with EGFR-mutated lung cancer   ADAURA is the first global trial for an EGFR inhibitor to show statisticallysignificant and clinically meaningful benefit in adjuvant treatment of lung cancer Plans for regulatory submission already underway   The ADAURA Phase III trial for Tagrisso (osimertinib) in the adjuvant treatment of patients with Stage IB, II and IIIA epidermal growth

Koselugo (selumetinib) approved in the US for NF1

13 April 2020 07:00 BST Koselugo (selumetinib) approved in US for paediatricpatients with neurofibromatosis type 1 plexiform neurofibromas First medicine approved to treat this rare and debilitating genetic condition AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo (selumetinib) for the treatment of paediatric patients two years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable

Mads Langaard is new Board Member of North Investment Group AB

Bolagsverket have received the request that Mads Langaard replace Ellen Hanetho as Board member of North Investment Group AB.Mads Langaard is the CFO of Frigaard Gruppen, the main shareholder of Sono Group. He has previously worked for Seatankers where he was a part of the Investment Team and worked with new investments, IR and communications. Mads has eight years of background from finance and five years from financial journalism and communications. Mads holds a bachelor's degree from BI Norwegian Business School and an MBA from Bergen Business School.

Gunnebo’s Interim Report January-March 2020 to be published 21 April – invitation to teleconference

Gunnebo will release Interim Report January-March 2020, Tuesday 21 April 2020, at 08:00 (CET) and will hold a teleconference at 08:15 (CET) on the same date.Interim Report January-March 2020 The press release, including a link to the full report, will be available on Gunnebo’s website, www.gunnebogroup.com, immediately after publishing. Teleconference 21 April at 08.15 (CET)To participate in the conference call, please dial in on:Sweden +46 8 519 993 83UK +44 33 3300 9260 Agenda08.10  Call in08.15  Presentation of the Interim Report by Gunnebo’s President & CEO, Stefan

ADJUSTED DIVIDEND PROPOSAL AND UPDATE DUE TO COVID-19

· The proposed dividend on Class A and Class B common shares will be adjusted from SEK 1.30 to SEK 0.65. · The adjustment to the dividend proposal is due to the higher level of uncertainty caused by COVID-19. · Limited impact of COVID-19 on the operations to date and solid financial position. · An additional dividend of SEK 0.65 on Class A and Class B common shares may be proposed at an Extraordinary General Meeting in the autumn. · The proposed dividend of SEK 2.00 per Class D common share and per preference share remains unchanged. Adjusted dividend proposalOne of the

Stayble has, together with APL, completed manufacturing of the investigational drug for the upcoming clinical phase 2b study.

The Company announces that the investigational drug (two doses of STA363 and placebo) now is manufactured and quality assured by our partner APL.CEO Andreas Gerward comments: The completion of the investigational drug is another valuable piece in the jigsaw for initiating our upcoming phase 2b study. We are now awaiting the approval of our previously submitted applications in the Netherlands, Spain and Russia, while we monitor the development of the COVID-19 situation and its impact on the study’s start date. The goal of the clinical phase 2b trial is to demonstrate safety, tolerability

Notice of Annual General Meeting

NOTICE OF FARON PHARMACEUTICALS LTD'S ANNUAL GENERAL MEETING Shareholders of Faron Pharmaceuticals Ltd (the "Company") are notified of the annual general meeting (the "AGM") to be held on 18 May 2020 at 10:00 a.m. (Finnish time) at the offices of the Company at Joukahaisenkatu 6, 20520 Turku, Finland. The registration of attendees and the distribution of voting slips will commence at the meeting venue at 9:00 a.m. (Finnish time). Due to the SARS-CoV-2 situation, the AGM will only be held if the number of participants at the meeting is low enough to allow the AGM to be conducted safely

There are no items matching the current filter
There are no more items matching the current filter
Back to top